21
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Reboxetine in the treatment of depression: Early clinical experience in the UK

, , , , , & show all
Pages 195-201 | Received 21 May 1998, Accepted 09 Jul 1998, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

S Kasper, N El Giamal & E Hilger. (2000) Reboxetine: the first selective noradrenaline re-uptake inhibitor. Expert Opinion on Pharmacotherapy 1:4, pages 771-782.
Read now

Articles from other publishers (7)

A. Önal, A. Olcay Sağirli, S. Müge Çetin & S. Toker. (2007) A Selective LC Method for the Determination of Reboxetine in Human Plasma with Fluorescence Detection. Chromatographia 66:S1, pages 103-107.
Crossref
Thomas Messer, Max Schmauss & Judith Lambert-Baumann. (2005) Efficacy and Tolerability of Reboxetine in Depressive Patients Treated in Routine Clinical Practice. CNS Drugs 19:1, pages 43-54.
Crossref
Daniel Öhman, Maria D. Cherma, Björn Norlander & Finn Bengtsson. (2003) Determination of Serum Reboxetine Enantiomers in Patients on Chronic Medication With Racemic Reboxetine. Therapeutic Drug Monitoring 25:2, pages 174-182.
Crossref
Daniel Öhman, Björn Norlander, Curt Peterson & Finn Bengtsson. (2002) Simultaneous determination of reboxetine and O-desethylreboxetine enantiomers using enantioselective reversed-phase high-performance liquid chromatography. Journal of Chromatography A 947:2, pages 247-254.
Crossref
G. Laux, B. Bondy, U. Breyer-Pfaff, A. Delini-Stula, H. Berzewski & C. Hiemke. 2002. Neuro-Psychopharmaka Ein Therapie-Handbuch. Neuro-Psychopharmaka Ein Therapie-Handbuch 365 402 .
Daniel ??hman, Bj??rn Norlander, Curt Peterson & Finn Bengtsson. (2001) Bioanalysis of Racemic Reboxetine and Its Desethylated Metabolite in a Therapeutic Drug Monitoring Setting Using Solid Phase Extraction and HPLC. Therapeutic Drug Monitoring 23:1, pages 27-34.
Crossref
David Healy & Helen Healy. (1998) The clinical pharmacologic profile of reboxetine: does it involve the putative neurobiological substrates of wellbeing?. Journal of Affective Disorders 51:3, pages 313-322.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.